¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Ä¡·áº°, ±Ë¾ç À¯Çüº°, ÃÖÁ¾ ¿ëµµº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)
U.S. Diabetic Foot Ulcer Treatment Market Size, Share & Trends Analysis Report By Treatment (Therapy Device, Wound Care Dressing), By Ulcer Type (Ulcer, Neuro-ischemic Ulcer), By End-use, And Segment Forecasts, 2024 - 2030
»óǰÄÚµå : 1511837
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 180 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽЏ®Æ÷Æ®¿¡ µû¸£¸é ¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå ±Ô¸ð´Â 2024-2030³â CAGR 5.25%·Î È®´ëÇϸç, 2030³â¿¡´Â 24¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå °³Ã´ÀÇ ÁÖ¿ä ¿äÀÎÀ¸·Î´Â Àü±¹ÀûÀÎ ´ç´¢º´ ¹ßº´·ü Áõ°¡, °í·ÉÈ­, Ä¡·á±â¼úÀÇ ¹ßÀü, ¿¬±¸°³¹ß ³ë·Â Áõ°¡, ¶óÀÌÇÁ½ºÅ¸ÀÏ ÆÐÅÏÀÇ º¯È­ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î Àα¸¹®Á¦¿¬±¸¼ÒÀÇ ¿¹Ãø¿¡ µû¸£¸é 65¼¼ ÀÌ»ó ¹Ì±¹Àα¸´Â 2022³â 5,800¸¸ ¸í¿¡¼­ 2050³â 8,200¸¸ ¸íÀ¸·Î 47% Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù.

´ç´¢º´¼º Á·±Ë¾çÀº ÈçÇÑ ÇÕº´ÁõÀ̱⠶§¹®¿¡ ¹Ì±¹³» ´ç´¢º´ÀÇ À¯ÇàÀº ½ÃÀå È®´ë¿¡ Å« ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ±¹Á¦´ç´¢º´¿¬¸Í¿¡ µû¸£¸é 2021³â ¹Ì±¹ÀÇ 20-79¼¼ ´ç´¢º´ ȯÀÚ´Â ¾à 3,221¸¸ ¸íÀ̸ç, 2045³â¿¡´Â 3,628¸¸ ¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ ÀÇ·á ±â¼ú ¹× Ä¡·á ¹æ¹ýÀÇ ¹ßÀüµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÷´Ü »óó °ü¸® Á¦Ç°, »ýü°øÇÐ Á¶Á÷, Àç»ýÀÇ·á ±â¼ú µîÀÇ Çõ½ÅÀº ´ç´¢º´¼º Á·±Ë¾ç °ü¸®¿¡ º¸´Ù È¿°úÀûÀ̰í È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù.

¶ÇÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾çÀÇ Á¶±â ¹ß°ß°ú ÀûÀýÇÑ Ä¡·áÀÇ Á߿伺¿¡ ´ëÇÑ ÀÇ·áÁø°ú ȯÀÚµéÀÇ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡¿Í ȯÀÚ ¸ðµÎ ´ç´¢º´¼º Á·±Ë¾çÀ» Á¶±â¿¡ ¹ß°ßÇϱâ À§Çؼ­´Â ¼¼½ÉÇÑ ¹ß °ü¸®¿Í Á¤±âÀûÀÎ °ËÁøÀÌ ÇÊ¿äÇÏ´Ù´Â °ÍÀ» ÀÌÇØÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÀÎ½Ä Áõ°¡´Â ´ç´¢º´ ÇÕº´Áõ °ü¸®¿¡ ´ëÇÑ Àû±ØÀûÀÎ Á¢±ÙÀ» À¯µµÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ°í ½É°¢ÇÑ ±Ë¾ç ¹ß»ýÀ» °¨¼Ò½ÃŰ´Â µ¥ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ç´¢º´¼º Á·ºÎ±Ë¾ç °ü¸®¸¦ À§ÇÑ Ä¡·á ¿É¼Ç°ú ±â¼úÀ» ¹ßÀü½Ã۱â À§Çؼ­´Â Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áö¼ÓÀûÀÎ ³ë·ÂÀÇ °á°ú·Î »õ·Î¿î Ä¡·á¹ý, Áø´Ü Åø, ¿¹¹æ¹ý µî Çõ½ÅÀûÀÎ ¼Ö·ç¼ÇÀÌ °³¹ßµÇ¾î ÀÇ·áÁøÀÌ ¼±ÅÃÇÒ ¼ö ÀÖ´Â ¼±ÅÃÀÇ ÆøÀÌ ³Ð¾îÁö°í ÀÖ½À´Ï´Ù.

´ëÇü ½ÃÀå ÁøÃâ±â¾÷ÀÇ Á¸Àç¿Í Á¦Ç° ½ÂÀÎ, Á¦Ç° Ãâ½Ã, Á¦ÈÞ, ÀμöÇÕº´(M&A), »ç¾÷ È®Àå µî ½ÃÀå °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇÑ °¢ ±â¾÷ÀÇ ´Ù¾çÇÑ ³ë·ÂÀÌ Àüü ½ÃÀå ¼ºÀå¿¡ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 4¿ù Molnlycke Health Care´Â »óó ¼¼Ã´ ¹× º¸½À Á¦Ç°ÀÎ Granudacyn Á¦Á¶·Î À¯¸íÇÑ ¿À½ºÆ®¸®¾ÆÀÇ P.G.F. Industry Solutions GmbH¸¦ ÀμöÇÒ °èȹÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¹Ì±¹ ´ç´¢º´¼º Á·ºÎ±Ë¾ç Ä¡·á ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå : Ä¡·á ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦5Àå ¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå : ±Ë¾ç À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦6Àå ¹Ì±¹ÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·á ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

U.S. Diabetic Foot Ulcer Treatment Market Growth & Trends:

The U.S. diabetic foot ulcer treatment market size is anticipated to reach USD 2.47 billion by 2030, expanding at a CAGR of 5.25% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include the increasing occurrence of diabetes nationwide, an aging population, advancements in treatment technology, rising research and development efforts, and shifts in lifestyle patterns. For instance, according to the Population Reference Bureau's projections, the population of Americans aged 65 and older is expected to rise from 58 million in 2022 to 82 million by the year 2050, reflecting a 47% increase.

The prevalence of diabetes in the U.S. plays a significant role in market expansion, as diabetic foot ulcers are a common complication of the disease. For instance, according to the International Diabetes Federation, in 2021 there were about 32.21 million diabetes patients aged 20-79 years in the U.S. which are further expected to increase to 36.28 million by 2045. Furthermore, the advancements in medical technology and treatment modalities contribute to the growth of the market. Innovations such as advanced wound care products, bioengineered tissues, and regenerative medicine techniques offer more effective and efficient solutions for diabetic foot ulcer management.

Furthermore, the increasing awareness among healthcare providers and patients of the importance of early detection and proper treatment of diabetic foot ulcers is driving the market growth. Both healthcare professionals and patients understand the necessity of careful foot care and regular screenings to catch diabetic foot ulcers early. This heightened awareness encourages a proactive approach to managing complications of diabetes, leading to better outcomes for patients and fewer severe ulcers. Additionally, ongoing research and development efforts are essential in advancing treatment options and technologies for managing diabetic foot ulcers. These continued efforts result in innovative solutions, such as new therapies, diagnostic tools, and preventive measures, which expand the options available to healthcare providers.

Presence of major market participants and various initiatives undertaken by them to stay competitive in the market such as product approval, product launch, partnership, merger and acquisition, expansion, etc. are expected to contribute to the overall market growth. For instance, in April 2024, Molnlycke Health Care has announced its plans to acquire P.G.F. Industry Solutions GmbH, an Austrian company known for producing Granudacyn, a line of wound cleansing and moisturizing products.

U.S. Diabetic Foot Ulcer Treatment Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. U.S. Diabetic Foot Ulcer Treatment Market Variables, Trends & Scope

Chapter 4. U.S. Diabetic Foot Ulcer Treatment Market: Treatment Estimates & Trend Analysis

Chapter 5. U.S. Diabetic Foot Ulcer Treatment Market: Ulcer Type Estimates & Trend Analysis

Chapter 6. U.S. Diabetic Foot Ulcer Treatment Market: End Use Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â